1988
DOI: 10.1016/0002-9149(88)90923-x
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous transluminal coronary angioplasty for angina pectoris after a non-Q-wave acute myocardial infarction

Abstract: Despite initially favorable prognosis in patients with non-Q-wave acute myocardlal infarction (AMI), long-term mortality In thls subset of patients appears to be similar to or even greater than that In patients wlth Q-wave AMI. The relatively poor late prognosis is primarily due to a hlgh lncldence of unstable angina and recurrent AMI. Between January 1982 and January 1987, 114 patients with suitable coronary narrowing underwent percutaneous translumlnal coronary angkplasty (PTCA) for angina pectoris (present … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1989
1989
2007
2007

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 25 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…Dialysis-associated arthropathy has been recognized for 10 years, but is still without successful cure or prevention measures, and represents a major obstacle to successful prolonged dialysis. Although no direct association has been established between the dialysis process and its development, there remains some suspicion that the prevention of dialysate endotoxin contamination and the use of a biocompatible membrane with greater solute clearance will contribute to its prevention; 16 however, these measures will entail increased costs.…”
mentioning
confidence: 99%
“…Dialysis-associated arthropathy has been recognized for 10 years, but is still without successful cure or prevention measures, and represents a major obstacle to successful prolonged dialysis. Although no direct association has been established between the dialysis process and its development, there remains some suspicion that the prevention of dialysate endotoxin contamination and the use of a biocompatible membrane with greater solute clearance will contribute to its prevention; 16 however, these measures will entail increased costs.…”
mentioning
confidence: 99%